期刊文献+

保乳手术治疗三阴乳腺癌的疗效观察 被引量:2

Curative effects of breast conserving operation in treatment of triple negative breast cancer
原文传递
导出
摘要 目的:探讨保乳手术治疗三阴乳腺癌的安全性及临床预后特点。方法157例乳腺癌患者根据其受体表达情况分为非三阴乳腺癌组(非三阴组,n=76)和三阴乳腺癌组(三阴组,n=81),比较两组临床病理特征、术后5年局部复发、远处转移及生存情况。结果三阴组年龄<35岁患者占17.3%,显著高于非三阴组的7.9%(χ^2=5.331,P<0.05);三阴组肿瘤大小≥5 cm患者占79.0%,显著高于非三阴组的59.2%(χ^2=7.022,P<0.05);三阴组有家族史和淋巴结阳性患者分别占9.9%和28.4%,均显著高于非三阴组的2.6%和17.1%(χ^2=6.283、4.865,均P<0.05);两组局部复发率、远处转移率和5年总生存率差异均无统计学意义(χ^2=2.559、2.829、2.361,均P>0.05);三阴组5年无病生存率为80.2%,显著低于非三阴组的94.7%(χ^2=6.572,P<0.05)。结论三阴乳腺癌患者发病年龄轻、肿瘤体积大、家族史比例高,行保乳手术后患者复发率、远处转移率和5年总生存率与非三阴组相当,安全性高,具有较好的临床应用价值。 Objective To investigate the safety and clinical prognosis of breast conserving operation in treat-ment of triple negative breast cancer.Methods 157 patients with breast cancer were divided into the non triple nega-tive breast cancer group (n=76) and triple negative breast cancer (n=81) according to its receptor expression,clin-ical pathological features, local recurrence after 5 years.Distant metastasis and survival situation were compared between two groups.Results The age〈35 years patients of triple negative group accounted 17.3%,significantly higher than 7.9%of the non triple negative group(χ^2=5.331,P〈0.05);the size of tumor≥5cm of triple negative group accounted 79.0%,significantly higher than 59.2% of the non triple negative group(χ^2=7.022,P〈0.05);The patients with positive family history and lymph nodes of the triple negative group were 9.9%and 28.4%,signifi-cantly higher than 2.6%and 17.1%of non triple negative group,the difference between the two groups was statisti-cally significant (χ^2=6.283,4.865,all P〈0.05);The local recurrence,distant metastasis rate and 5 year survival rates between the two group were not significantly different(χ^2=2.559,2.829,2.361,all P〉0.05);The 5 year dis-ease free survival rate of the triple negative group was 80.25%,significantly lower than 94.74%of the non triple neg-ative group (χ^2=6.572,P〈0.05).Conclusion The patients with triple negative breast cancer is younger,their tumor size is large and has a high proportion of family history.Their recurrence rate,distant metastasis rate and 5 year overall survival rate are as better as the patients with non triple negative breast cancer after breast preservation opera-tion,which has high security and good clinical application value.
出处 《中国基层医药》 CAS 2014年第22期3453-3454,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 乳腺肿瘤 手术治疗 Breast neoplasms Surgical operation
  • 相关文献

参考文献15

二级参考文献125

  • 1雷玉涛,赵红梅,侯宽永.乳腺癌保乳手术方式的选择[J].中国微创外科杂志,2004,4(4):296-297. 被引量:13
  • 2RAKHA E A, EL - SAYED M E, GREEN A R, et al. Prognostic markers in triple - negative breast cancer [ J]. Cancer, 2007, 109 (1) : 25 -32. 被引量:1
  • 3BANERJEE S, REIS - FILHO J S, ASHLEY S, et al. Basal - like breast carcinomas: clinical outcome and response to chemotherapy[J]. J Clin Pathol, 2006, 59(7) : 729 -735. 被引量:1
  • 4CAREY L A, PEROU C M, LIVASY C A, et at. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study [j]. JAMA, 2006, 295(21): 2 492-2 502. 被引量:1
  • 5BAUER K R, BROWN M, CRESS R D, et al. Descriptive analysis of estrogen receptor (ER) - negative, progesterone receptor (PR) - negative, and HER2 - negative invasive breast cancer, the so - called triple - negative phenotype: a population - based study from the California cancer Registry[ J]. Cancer, 2007, 109.(9) : 1 721 - 1 728. 被引量:1
  • 6TURNER N C, REIS - FILHO J S. Basal - like breast cancer and the BRCA1 phenotype[J]. Oncogene, 2006, 25 (43) : 5 846 - 5 853. 被引量:1
  • 7MERSIN H, YILDIRIM E, BERBEROGLU U, et al. The prog- nostic importance of triple negative breast carcinoma[ J ]. Breast, 2008, 17(4): 341 -346. 被引量:1
  • 8HOFMANN M, STOSS O, GAISER T, et al. Central HER2 IHC and FISH analysis in a trastuzumab (Herceptin) phase II monotherapy study: assessment of test sensitivity and impact of chromosome 17 polysomy [J]. J Clin Pathol, 2008, 61 (1) : 89 -94. 被引量:1
  • 9SIZIOPIKOU K P, COBLEIGH M. The basal subtype of breast carcinomas may represent the group of breast tumot,s that could benefit from EGFR - targeted therapies[J]. Breast, 2007, 16 (1) :104-107. 被引量:1
  • 10RheeJ, Hart SW, Oh DY, et al. The clixticopathologic characteristics and prognostic significance of triple--negativity in node--negative breast cancer[J]. BMC Cancer, 2008, 8: 307-344. 被引量:1

共引文献123

同被引文献11

  • 1Liedtke C,Broglio K,Moulder S,et al.Prognostic impact of discord- ance between triple-receptor measurements in primary and recurrent breast cancer[J].Ann oncol,2009,20(12):1953-1958. 被引量:1
  • 2Rakha EAiEl-Sayed M E,Green AR,et al.Prognostic markers in tri- ple-negative breast cancer[J].Cancer,2007,109(1):25-32. 被引量:1
  • 3Wirapati P,Sotirlou C,Kunkel S,et al.Meta-analysis of gene expres- sion profiles in breast cancer:toward a unified understanding of breast cancer subtyping and prognosis signa-tures[J].Breast Cancer Res,2008,10(4):1165. 被引量:1
  • 4Nielsen TO,Hsu FD,Jensen K,et al.Immunohistochemical and clini- cal characterization of the basal-like subtype of invasive breast carci- noma[J].Clin Cancer Bes,2004,10(16):5367-5374. 被引量:1
  • 5Haffty BG,Yang QF,Reiss M,et al.Locoregional Relapse and Distant Me,tastaais in Conservatively Managed Triple Negative Early-Stage Breast Cancer[J].J Clin Oneol,2006,24(36):5652-5657. 被引量:1
  • 6Carey LA,Perou CM,Livasy CA,et al.Race,breast cancer subtypes,and survival in the Carolina Breast Cancer Study[J].JAMA,2006,295(21):2492-2502. 被引量:1
  • 7Carey LA,Dees EC,Sawyer L,et al.The triple negative paradox._pri- mary tumor ehemosensitivity of breast cancer subtypes[J].Clin Canc- er Res,2007,13(8):2329-2334. 被引量:1
  • 8张毅,张颖,修海清,李玉军,王海波,梁军.三阴性乳腺癌TNM分期的临床特点及影响预后的危险因素[J].中华乳腺病杂志(电子版),2012,6(2):30-35. 被引量:28
  • 9赵玲,曹玲,刘士新.早期三阴乳腺癌患者保乳治疗的预后分析[J].中国肿瘤,2012,21(7):548-551. 被引量:6
  • 10陈玉娟,王晓东,汪静.三阴乳腺癌的特征及治疗现状[J].中国普外基础与临床杂志,2012,19(9):1024-1027. 被引量:21

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部